Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Mouse ATG9A ELISA Kit (AC3870)
Cat.#: ASET-2459
Specifications
Description Mouse ATG9A ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse ATG9A concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 6.97 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 100-1600 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2060 Porcine GDNF ELISA Kit (AC3471) Quantitative inquiry ASET-2205 Human alpha Synuclein ELISA Kit (AC3616) Quantitative inquiry ASET-1582 Canine beta Nerve Growth Factor ELISA Kit (AC2993) Quantitative inquiry ASET-2498 Human SPOCK1 ELISA Kit (AC3909) Quantitative inquiry ASET-1998 Human Vaspin ELISA Kit (AC3409) Quantitative inquiry ASET-2541 Human CD133 ELISA Kit (AC3952) Quantitative inquiry ASET-1844 Human PSD95 ELISA Kit (AC3255) Quantitative inquiry ASET-1024 Chicken FGF2 ELISA Kit (AC2435) Quantitative inquiry ASET-2335 Human Ghrelin ELISA Kit (AC3746) Quantitative inquiry ASET-1297 Rat Myelin Basic Protein ELISA Kit (AC2708) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket